Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas H Brand

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
International Journal of Radiation Oncology, Biology, Physics|July 17, 2022
Fractionation Choice for Elective Lymph Node Radiation Therapy in Prostate Cancer: Slightly More to CHIRP AboutDouglas H Brand, Alison C Tree
The Lancet. Oncology|December 5, 2019
Optimal patient selection for stereotactic body radiotherapy - Authors' replyDouglas H Brand, Alison C Tree, Emma Hall, et al.
International Journal of Radiation Oncology, Biology, Physics|April 3, 2024
ImmunoChemoradiation for Non-Small Cell Lung Cancer: A Meta-Analysis of Factors Influencing Survival Benefit in Combination TrialsHuei-Tyng Huang, Douglas H Brand, John D Fenwick, et al.
Journal of Applied Clinical Medical Physics|February 14, 2019
Improving fiducial and prostate capsule visualization for radiotherapy planning using MRIAngela U Pathmanathan, Maria A Schmidt, Douglas H Brand, et al.
Cancers|October 14, 2022
Dose-Response Analysis Describes Particularly Rapid Repopulation of Non-Small Cell Lung Cancer during Concurrent ChemoradiotherapyHuei-Tyng Huang, Michael G Nix, Douglas H Brand, et al.
Clinical and Translational Radiation Oncology|April 8, 2024
Developing and validating a simple urethra surrogate model to facilitate dosimetric analysis to predict genitourinary toxicityRagu Ratnakumaran, Jonathan Mohajer, Samuel J Withey, et al.
European Urology|October 23, 2025
Exploring Factors Associated with Late Urinary Toxicity After Prostate Stereotactic Body Radiotherapy: Findings from the PACE-B StudyRagu Ratnakumaran, Douglas H Brand, Archana Sasitharan, et al.
International Journal of Radiation Oncology, Biology, Physics|January 25, 2025
Dosimetric Comparison of CyberKnife and Conventional Linac Prostate Stereotactic Body Radiation Therapy Plans: Analysis of the PACE-B StudyRagu Ratnakumaran, Archana Sasitharan, Asadullah Khan, et al.
International Journal of Radiation Oncology, Biology, Physics|August 19, 2022
The Fraction Size Sensitivity of Late Genitourinary Toxicity: Analysis of Alpha/Beta (α/β) Ratios in the CHHiP TrialDouglas H Brand, Sarah C Brüningk, Anna Wilkins, et al.
International Journal of Radiation Oncology, Biology, Physics|July 11, 2023
Gastrointestinal Toxicity Prediction Not Influenced by Rectal Contour or Dose-Volume Histogram DefinitionDouglas H Brand, Sarah C Brüningk, Anna Wilkins, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
International Journal of Radiation Oncology, Biology, Physics|July 17, 2022
Fractionation Choice for Elective Lymph Node Radiation Therapy in Prostate Cancer: Slightly More to CHIRP AboutDouglas H Brand, Alison C Tree
The Lancet. Oncology|December 5, 2019
Optimal patient selection for stereotactic body radiotherapy - Authors' replyDouglas H Brand, Alison C Tree, Emma Hall, et al.
International Journal of Radiation Oncology, Biology, Physics|April 3, 2024
ImmunoChemoradiation for Non-Small Cell Lung Cancer: A Meta-Analysis of Factors Influencing Survival Benefit in Combination TrialsHuei-Tyng Huang, Douglas H Brand, John D Fenwick, et al.
Journal of Applied Clinical Medical Physics|February 14, 2019
Improving fiducial and prostate capsule visualization for radiotherapy planning using MRIAngela U Pathmanathan, Maria A Schmidt, Douglas H Brand, et al.
Cancers|October 14, 2022
Dose-Response Analysis Describes Particularly Rapid Repopulation of Non-Small Cell Lung Cancer during Concurrent ChemoradiotherapyHuei-Tyng Huang, Michael G Nix, Douglas H Brand, et al.
Clinical and Translational Radiation Oncology|April 8, 2024
Developing and validating a simple urethra surrogate model to facilitate dosimetric analysis to predict genitourinary toxicityRagu Ratnakumaran, Jonathan Mohajer, Samuel J Withey, et al.
European Urology|October 23, 2025
Exploring Factors Associated with Late Urinary Toxicity After Prostate Stereotactic Body Radiotherapy: Findings from the PACE-B StudyRagu Ratnakumaran, Douglas H Brand, Archana Sasitharan, et al.
International Journal of Radiation Oncology, Biology, Physics|January 25, 2025
Dosimetric Comparison of CyberKnife and Conventional Linac Prostate Stereotactic Body Radiation Therapy Plans: Analysis of the PACE-B StudyRagu Ratnakumaran, Archana Sasitharan, Asadullah Khan, et al.
International Journal of Radiation Oncology, Biology, Physics|August 19, 2022
The Fraction Size Sensitivity of Late Genitourinary Toxicity: Analysis of Alpha/Beta (α/β) Ratios in the CHHiP TrialDouglas H Brand, Sarah C Brüningk, Anna Wilkins, et al.
International Journal of Radiation Oncology, Biology, Physics|July 11, 2023
Gastrointestinal Toxicity Prediction Not Influenced by Rectal Contour or Dose-Volume Histogram DefinitionDouglas H Brand, Sarah C Brüningk, Anna Wilkins, et al.
Pageof 2